Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Articles from Nancy Dvorin:

Perspective & Commentary

Digital Edition: MedTech Strategist November 2025

Medtech is a hot area for private equity investors: deal flow through the 3rd quarter of this year is the second highest on record; Ethan Korngold on Abbott's plans to transform interventional cardiology with AI-guided advanced imaging; Digital pathology may be the specialty most able to drive precision medicine into the future; ensuring cybersecurity in medtech; Lifecare aims to make the world's smallest implantable CGM ; plus profiles of AcuityMD, Epiminder, and RenovoRx.

Read Article